Ultromics

UltromicsUltromics
Ultromics

Ultromics

AI-powered software for cardiac ultrasound analysis and diagnosis.

DR 492017Active84Oxford, United Kingdom
Rate

About

Ultromics develops AI-driven software that analyzes cardiac ultrasound images to provide faster, more accurate diagnoses for heart conditions. Their platform aims to improve patient outcomes and reduce the burden on healthcare professionals by automating complex analysis tasks.
Frequently asked

What does Ultromics do?

Ultromics develops AI-driven software that analyzes cardiac ultrasound images to provide faster, more accurate diagnoses for heart conditions. Their platform aims to improve patient outcomes and reduce the burden on healthcare professionals by automating complex analysis tasks.

What is Ultromics's revenue?

StartupHub estimates Ultromics's annual revenue at $19.4M (range $12.2M to $29.8M, 64% confidence), based on comparable companies in the sector.

What is Ultromics's valuation?

StartupHub estimates Ultromics's effective valuation at $423.9M (range $258.5M to $620.4M, 19% confidence), based on comparable companies in the sector.

How much funding has Ultromics raised?

Ultromics has raised a total of $103M in funding. The most recent round on record is Series C.

Where is Ultromics headquartered?

Ultromics is headquartered in Oxford, United Kingdom.

When was Ultromics founded?

Ultromics was founded in 2017.

What industry does Ultromics operate in?

Ultromics operates in HealthTech, MedTech, AI-Driven Protein Design, Clinical Trials, Digital Twin Healthcare, Computer Vision.

How many employees does Ultromics have?

Ultromics has approximately 84 people on record.

HEADCOUNT
84
DOMAIN RATING
49
Comments

No comments yet. Be the first to share your take.